FDA Requests Ho-Hum Paperwork for Keeping Snacks Safe
Published Date: 9/5/2025
Notice
Summary
The FDA is asking for approval to collect info about food safety programs from companies that make food. This helps keep our food safe and makes sure everyone follows the rules. If you’re in the food business, get ready for some paperwork soon, but no big costs are expected.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Food makers face new paperwork
The FDA is asking OMB to approve collecting information about food safety programs from companies that make food. If you run a food business, expect to provide paperwork about your safety program soon, but the FDA says no big costs are expected.
Info collection aims to improve food safety
The FDA says collecting this information will help keep food safe and make sure food companies follow the rules. This change is intended to protect consumers by improving oversight of food safety programs.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-17050, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Report of Mail Order Transactions
The DEA is asking to keep collecting info about mail order drug sales without changing the current form. This affects businesses that sell drugs by mail and helps the government keep track of these transactions. No new costs or deadlines are coming, just a smooth extension to keep things running.
Next: 2025-17059, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases (NIAID) is holding a private meeting from December 8-10, 2025, to review the skills and work of its researchers. This closed meeting affects NIAID staff and helps ensure top-notch science without sharing personal details publicly. No new funding or policy changes are announced, but the review supports ongoing excellence in infectious disease research.